Drug-eluting balloon therapy for femoropopliteal occlusive disease: Predictors of outcome with a special emphasis on calcium

Journal of Endovascular Therapy

Volumn 22, Issue 5, 2015, Pages 727-733

  Tepe, Gunnar ^a   Beschorner, Ulrich ^b   Ruether, Charlotte ^a   Fischer, Imma ^c   Pfaffinger, Peter ^a   Noory, Elias ^b   Zeller, Thomas ^b  

^a Department of Internal Medicine III   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c Department of Biostatistics ^*  (Germany)

Author keywords

Angioplasty; Calcification; Drug coated balloon; Drug eluting balloon; Late lumen loss; Peripheral artery disease; Popliteal artery; Superficial femoral artery

Indexed keywords

CALCIUM; BIOMATERIAL; CARDIOVASCULAR AGENT;

AGED; ARTERY CALCIFICATION; ARTICLE; BALLOON; CAROTID ARTERY DISEASE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG ELUTING BALLOON; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUPERFICIAL FEMORAL ARTERY; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DEVICES; EQUIPMENT DESIGN; FEMORAL ARTERY; GERMANY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VASCULAR CALCIFICATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; GERMANY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR CALCIFICATION;

EID: 84942090909     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1177/1526602815600156     Document Type: Article

References (10)

1. Tepe G, Schmitmeier S, Zeller T. Drug-coated balloons in peripheral arterial disease. EuroIntervention. 2011;7(suppl K):K70-K76.
2. Loh JP, Barbash IM, Waksman R. The current status of drugcoated balloons in percutaneous coronary and peripheral interventions. EuroIntervention. 2013;9:979-988.
3. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.
4. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
5. Scheinert D, Duda S, Zeller T, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7:10-19.
6. Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831-840.
7. Fanelli F, Cannavale A, Boatta E, et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012;19:571-580.
8. Fanelli F, Cannavale A, Gazzetti M, et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol. 2014;37:898-907.
9. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83:E212-E220.
10. Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360 degrees trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014;26:355-360.